Literature DB >> 10668217

Apoptosis in cancer: therapeutic implications.

A Negoescu1.   

Abstract

This review outlines the principal limitations of the mechanisms of active cell death (ACD, apoptosis) as the basis of tumorigenesis and the rationale of almost all therapies of malignancy. The concentration of cancer therapy in the direction of ACD induction is presented as both the result of progressive understanding of the mechanisms of apoptosis and that of the favourable tumor environment for ACD signal transmission. The latter property induces the by-stander killing of cancer cells, a fundamental mechanism because efficiency of all known methods of cancer treatment is far below 100%. Finally, recent results and hypotheses regarding cancer gene therapy based on final inductors of apoptosis and endogeneous ACD inhibitors in tumors are evaluated.

Entities:  

Mesh:

Year:  2000        PMID: 10668217     DOI: 10.14670/HH-15.281

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  2 in total

1.  ARP2 a novel protein involved in apoptosis of LNCaP cells shares a high degree homology with splicing factor Prp8.

Authors:  J V Tapia-Vieyra; R O Arellano; J Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  ARP2, a novel pro-apoptotic protein expressed in epithelial prostate cancer LNCaP cells and epithelial ovary CHO transformed cells.

Authors:  Jaime Mas-Oliva; Enrique Navarro-Vidal; Juana Virginia Tapia-Vieyra
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.